These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31289826)

  • 1. Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
    Boutrot M; Azougagh K; Guinard J; Boulain T; Barbier F
    J Antimicrob Chemother; 2019 Oct; 74(10):3095-3103. PubMed ID: 31289826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.
    Armand-Lefèvre L; Angebault C; Barbier F; Hamelet E; Defrance G; Ruppé E; Bronchard R; Lepeule R; Lucet JC; El Mniai A; Wolff M; Montravers P; Plésiat P; Andremont A
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1488-95. PubMed ID: 23318796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of topical antibiotics on eradication and acquisition of third-generation cephalosporin and carbapenem-resistant Gram-negative bacteria in ICU patients; a post hoc analysis from a multicentre cluster-randomized trial.
    Plantinga NL; Wittekamp BHJ; Brun-Buisson C; Bonten MJM;
    Clin Microbiol Infect; 2020 Apr; 26(4):485-491. PubMed ID: 31421272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
    Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
    Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
    Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance in gram-negative bacilli in a cardiac intensive care unit in India: risk factors and outcome.
    Pawar M; Mehta Y; Purohit A; Trehan N; Rosenthal VD
    Ann Card Anaesth; 2008; 11(1):20-6. PubMed ID: 18182755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia.
    Villegas MV; Briceno DF; Ruiz SJ; Furtado GH; Nicolau DP
    Braz J Infect Dis; 2011; 15(5):413-9. PubMed ID: 22230846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
    Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of nosocomial pneumonia in infants after cardiac surgery.
    Tan L; Sun X; Zhu X; Zhang Z; Li J; Shu Q
    Chest; 2004 Feb; 125(2):410-7. PubMed ID: 14769717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.
    Uc-Cachón AH; Gracida-Osorno C; Luna-Chi IG; Jiménez-Guillermo JG; Molina-Salinas GM
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540314
    [No Abstract]   [Full Text] [Related]  

  • 13. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program-Asia-Pacific Region.
    Roberts JA; Kwa A; Montakantikul P; Gomersall C; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2011 Mar; 37(3):225-9. PubMed ID: 21168997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study.
    Tacconelli E; Górska A; De Angelis G; Lammens C; Restuccia G; Schrenzel J; Huson DH; Carević B; Preoţescu L; Carmeli Y; Kazma M; Spanu T; Carrara E; Malhotra-Kumar S; Gladstone BP
    Clin Microbiol Infect; 2020 Jan; 26(1):87-94. PubMed ID: 31128285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term adherence to a 5 day antibiotic course guideline for treatment of intensive care unit (ICU)-associated Gram-negative infections.
    Edgeworth JD; Chis Ster I; Wyncoll D; Shankar-Hari M; McKenzie CA
    J Antimicrob Chemother; 2014 Jun; 69(6):1688-94. PubMed ID: 24573413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the United States between 1993 and 2004.
    Eagye KJ; Nicolau DP; Lockhart SR; Quinn JP; Doern GV; Gallagher G; Abramson MA
    Ann Clin Microbiol Antimicrob; 2007 Oct; 6():11. PubMed ID: 17908321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
    Maina JW; Mutua JM; Musyoki AM
    BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.